Morepen Laboratories Limited (MOREPENLAB.NS)

INR 49.25

(-6.62%)

Long Term Debt Summary of Morepen Laboratories Limited

  • Morepen Laboratories Limited's latest annual long term debt in 2023 was 33.64 Million INR , up 260.36% from previous year.
  • Morepen Laboratories Limited's latest quarterly long term debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Morepen Laboratories Limited reported annual long term debt of 9.33 Million INR in 2022, down -29.34% from previous year.
  • Morepen Laboratories Limited reported annual long term debt of 13.21 Million INR in 2021, up 59.5% from previous year.
  • Morepen Laboratories Limited reported quarterly long term debt of 33.64 Million INR for 2023 FY, up 260.36% from previous quarter.
  • Morepen Laboratories Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Morepen Laboratories Limited (2023 - 2006)

Historical Annual Long Term Debt of Morepen Laboratories Limited (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 33.64 Million INR 260.36%
2022 9.33 Million INR -29.34%
2021 13.21 Million INR 59.5%
2020 8.28 Million INR -10.42%
2019 9.24 Million INR -49.45%
2018 18.29 Million INR -37.94%
2017 29.47 Million INR 113.05%
2016 13.83 Million INR -96.81%
2015 434.11 Million INR -30.29%
2014 622.7 Million INR -16.73%
2013 747.8 Million INR -20.99%
2012 946.5 Million INR -16.89%
2011 1.13 Billion INR -19.82%
2010 1.42 Billion INR 1.65%
2009 1.39 Billion INR -50.17%
2008 2.8 Billion INR -4.06%
2007 2.92 Billion INR -41.35%
2006 4.98 Billion INR 0.0%

Peer Long Term Debt Comparison of Morepen Laboratories Limited

Name Long Term Debt Long Term Debt Difference
Aarti Drugs Limited 2.75 Billion INR 98.778%
Aarti Pharmalabs Limited 400 Thousand INR -8310.0%
Albert David Limited 6.01 Million INR -459.176%
Alembic Pharmaceuticals Limited 628.8 Million INR 94.65%
Bafna Pharmaceuticals Limited 107.53 Million INR 68.716%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
FDC Limited 2.46 Million INR -1264.152%
Gufic Biosciences Limited 1.53 Billion INR 97.815%
Hikal Limited 4.22 Billion INR 99.204%
Ind-Swift Laboratories Limited 111.62 Million INR 69.864%
Ind-Swift Limited 10.09 Billion INR 99.667%
Jubilant Pharmova Limited 31.67 Billion INR 99.894%
Lincoln Pharmaceuticals Limited - INR -Infinity%
Mangalam Drugs & Organics Limited 133.54 Million INR 74.809%
Medico Remedies Limited 8.67 Million INR -287.915%
Nectar Lifesciences Limited 1.4 Billion INR 97.602%
Orchid Pharma Limited 1.2 Billion INR 97.207%
Procter & Gamble Health Limited 68.8 Million INR 51.105%
RPG Life Sciences Limited -30.3 Million INR 211.023%
Alembic Limited 73.9 Million INR 54.479%
Alkem Laboratories Limited 400 Million INR 91.59%
Bajaj HealthCare Limited 650.34 Million INR 94.827%
Brooks Laboratories Limited 3.56 Million INR -843.619%
Eris Lifesciences Limited 6.54 Billion INR 99.486%
Glenmark Life Sciences Limited 147.61 Million INR 77.21%
Sigachi Industries Limited 265.79 Million INR 87.344%
Solara Active Pharma Sciences Limited 1.17 Billion INR 97.136%
Sun Pharmaceutical Industries Limited 13.3 Million INR -152.932%
Innova Captab Limited 2.1 Billion INR 98.402%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Suven Pharmaceuticals Limited 212.35 Million INR 84.159%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 55.485%
Themis Medicare Limited 267.74 Million INR 87.436%
Unichem Laboratories Limited 382.22 Million INR 91.199%
Vaishali Pharma Limited 35.98 Million INR 6.511%
Venus Remedies Limited 386.8 Million INR 91.303%
Wanbury Limited 820 Million INR 95.898%
Windlas Biotech Limited 20.18 Million INR -66.7%
ZIM Laboratories Limited 356 Million INR 90.551%
Kilitch Drugs (India) Limited - INR -Infinity%
Lupin Limited 1.55 Billion INR 97.834%
Sakar Healthcare Limited 549.55 Million INR 93.879%
Aurobindo Pharma Limited 21.34 Billion INR 99.842%
Divi's Laboratories Limited 20 Million INR -68.2%
AstraZeneca Pharma India Limited 27.83 Million INR -20.851%
Mankind Pharma Limited 325.81 Million INR 89.675%
Sequent Scientific Limited 1.42 Billion INR 97.643%
Laurus Labs Limited 7.98 Billion INR 99.579%
Neuland Laboratories Limited 449.2 Million INR 92.511%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 85.77%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 97.782%
Zydus Lifesciences Limited 251 Million INR 86.598%
Amrutanjan Health Care Limited 13.96 Million INR -140.836%
Wockhardt Limited 8.91 Billion INR 99.622%
Bal Pharma Limited 363.82 Million INR 90.754%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.438%
Bliss GVS Pharma Limited 355.92 Million INR 90.548%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 9.2 Million INR -265.652%
Shilpa Medicare Limited 5.6 Billion INR 99.399%
Valiant Laboratories Limited 750.89 Million INR 95.52%
Ajanta Pharma Limited 235.2 Million INR 85.697%
Hester Biosciences Limited 1.81 Billion INR 98.149%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR -4.33%
Granules India Limited 689.71 Million INR 95.123%
Medicamen Biotech Limited 12.55 Million INR -167.941%
Ipca Laboratories Limited 5.8 Billion INR 99.42%
Syncom Formulations (India) Limited -1.21 Million INR 2859.639%
Piramal Enterprises Limited 535.85 Billion INR 99.994%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.79%
NATCO Pharma Limited 53 Million INR 36.528%
Suven Life Sciences Limited - INR -Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 98.167%
Strides Pharma Science Limited 6.71 Billion INR 99.499%
Indoco Remedies Limited 3.51 Billion INR 99.044%
Alpa Laboratories Limited - INR -Infinity%
Lasa Supergenerics Limited - INR -Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 68.443%